Evidence map›Paper›PMID 37531401›Full record

ArticlePLoS genetics2023

The bacterial genetic determinants of Escherichia coli capacity to cause bloodstream infections in humans.

Judit Burgaya, Julie Marin, Guilhem Royer, Bénédicte Condamine, Benoit Gachet, Olivier Clermont, Françoise Jaureguy, Charles Burdet, Agnès Lefort, Victoire de Lastours and 4 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Is Virulence GeneInfectious disease reports · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Judit BurgayaInstitute for Molecular Bacteriology, TWINCORE Centre for Experimental and Clinical Infection Research, a joint venture between the Hannover Medical School (MHH) and the Helmholtz Centre for Infection Research (HZI), Hannover, Germany.
Julie MarinUniversité Sorbonne Paris Nord, INSERM, IAME, Bobigny, France.ORCID 0000-0002-7160-9302
Guilhem RoyerUniversité Paris Cité, INSERM, IAME, Paris, France.ORCID 0000-0001-9092-8336
Bénédicte CondamineUniversité Paris Cité, INSERM, IAME, Paris, France.
Benoit GachetUniversité Paris Cité, INSERM, IAME, Paris, France.
Olivier ClermontUniversité Paris Cité, INSERM, IAME, Paris, France.
Françoise JaureguyUniversité Sorbonne Paris Nord, INSERM, IAME, Bobigny, France.
Charles BurdetUniversité Paris Cité, INSERM, IAME, Paris, France.
Agnès LefortUniversité Paris Cité, INSERM, IAME, Paris, France.
Victoire de LastoursUniversité Paris Cité, INSERM, IAME, Paris, France.ORCID 0000-0003-1160-2069
Erick DenamurUniversité Paris Cité, INSERM, IAME, Paris, France.ORCID 0000-0002-7860-1717
Marco GalardiniInstitute for Molecular Bacteriology, TWINCORE Centre for Experimental and Clinical Infection Research, a joint venture between the Hannover Medical School (MHH) and the Helmholtz Centre for Infection Research (HZI), Hannover, Germany.ORCID 0000-0003-2018-8242
François BlanquartCenter for Interdisciplinary Research in Biology, Collège de France, CNRS UMR7241 / INSERM U1050, PSL Research University, Paris, France.
Colibafi/Septicoli & Coliville groups
Inserm · FRCentre National de la Recherche Scientifique · FRMedizinische Hochschule Hannover · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Escherichia coli is both a highly prevalent commensal and a major opportunistic pathogen causing bloodstream infections (BSI). A systematic analysis characterizing the genomic determinants of extra-intestinal pathogenic vs. commensal isolates in human populations, which could inform mechanisms of pathogenesis, diagnostic, prevention and treatment is still lacking. We used a collection of 912 BSI and 370 commensal E. coli isolates collected in France over a 17-year period (2000-2017). We compared their pangenomes, genetic backgrounds (phylogroups, STs, O groups), presence of virulence-associated genes (VAGs) and antimicrobial resistance genes, finding significant differences in all comparisons between commensal and BSI isolates. A machine learning linear model trained on all the genetic variants derived from the pangenome and controlling for population structure reveals similar differences in VAGs, discovers new variants associated with pathogenicity (capacity to cause BSI), and accurately classifies BSI vs. commensal strains. Pathogenicity is a highly heritable trait, with up to 69% of the variance explained by bacterial genetic variants. Lastly, complementing our commensal collection with an older collection from 1980, we predict that pathogenicity continuously increased through 1980, 2000, to 2010. Together our findings imply that E. coli exhibit substantial genetic variation contributing to the transition between commensalism and pathogenicity and that this species evolved towards higher pathogenicity.

Indexed as

Escherichia coli InfectionsSepsisEscherichia coliGenes, BacterialHumansPhylogenyVirulence

Identifiers

PMID37531401
PMCPMC10395866
OpenAlexW4385481089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.